| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.947 | 0.002 | 0.947 | 5 Hydroxytryptamine uptake inhibitor | 0.919 0.002 CID_36060 | ||
| 0.789 | 0.004 | 0.789 | Spasmolytic | 0.676 0.007 CID_36060 | ||
| 0.73 | 0.002 | 0.73 | Adrenaline uptake inhibitor | 0.607 0.003 CID_36060 | ||
| 0.704 | 0.002 | 0.704 | Dopamine transporter inhibitor | 0.703 0.002 CID_36060 | ||
| 0.685 | 0.004 | 0.685 | Psychostimulant | 0.534 0.008 CID_36060 | ||
| 0.661 | 0.009 | 0.661 | Vasodilator, peripheral | 0.51 0.026 CID_36060 | ||
| 0.62 | 0.004 | 0.62 | Anesthetic local | 0.416 0.006 CID_36060 | ||
| 0.588 | 0.007 | 0.588 | Calcium channel L-type activator | 0.317 0.143 CID_36060 | ||
| 0.566 | 0.014 | 0.589 | Histamine release inhibitor | 0.589 0.011 CID_36060 | CID_36060 | |
| 0.52 | 0.004 | 0.52 | Sigma 1 receptor antagonist | 0.483 0.004 CID_36060 | ||
| 0.463 | 0.004 | 0.463 | Nav1.3 sodium channel blocker | 0.289 0.01 CID_36060 | ||
| 0.457 | 0.022 | 0.457 | Vasodilator, coronary | 0.437 0.026 CID_36060 | ||
| 0.462 | 0.034 | 0.543 | 5 Hydroxytryptamine release stimulant | 0.543 0.021 CID_36060 | CID_36060 | |
| 0.421 | 0.006 | 0.421 | Nav1.2 sodium channel blocker | 0.356 0.01 CID_36060 | ||
| 0.408 | 0.022 | 0.408 | Calcium channel activator | 0.405 0.023 CID_36060 | ||
| 0.39 | 0.004 | 0.39 | Nav1.6 sodium channel blocker | 0.295 0.006 CID_36060 | ||
| 0.391 | 0.006 | 0.391 | Acetylcholine M1 receptor antagonist | 0.344 0.009 CID_36060 | ||
| 0.377 | 0.005 | 0.377 | Sigma receptor antagonist | 0.333 0.005 CID_36060 | ||
| 0.381 | 0.009 | 0.381 | Cholinergic antagonist | 0.31 0.013 CID_36060 | ||
| 0.367 | 0.005 | 0.367 | Alpha 2b adrenoreceptor antagonist | 0.268 0.012 CID_36060 | ||
| 0.434 | 0.073 | 0.434 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.381 0.118 CID_36060 | ||
| 0.358 | 0.009 | 0.358 | Acetylcholine antagonist | 0.283 0.015 CID_36060 | ||
| 0.35 | 0.004 | 0.35 | Dopamine uptake inhibitor | 0.218 0.005 CID_36060 | ||
| 0.345 | 0.005 | 0.345 | Nav1.1 sodium channel blocker | 0.342 0.006 CID_36060 | ||
| 0.337 | 0.003 | 0.337 | Sphingomyelinase inhibitor | 0.335 0.003 CID_36060 | ||
| 0.355 | 0.024 | 0.371 | Cyclic AMP phosphodiesterase inhibitor | 0.371 0.021 CID_36060 | CID_36060 | |
| 0.331 | 0.003 | 0.429 | Toll-Like receptor 3 antagonist | 0.429 0.002 CID_36060 | CID_36060 | |
| 0.39 | 0.066 | 0.423 | GABA C receptor rho-3 antagonist | 0.423 0.052 CID_36060 | CID_36060 | |
| 0.324 | 0.004 | 0.324 | 5 Hydroxytryptamine 3E antagonist | 0.304 0.005 CID_36060 | ||
| 0.349 | 0.039 | 0.42 | Cardiotonic | 0.42 0.025 CID_36060 | CID_36060 | |
| 0.317 | 0.008 | 0.317 | Acetylcholine muscarinic antagonist | 0.256 0.014 CID_36060 | ||
| 0.358 | 0.054 | 0.488 | Aldehyde oxidase inhibitor | 0.488 0.034 CID_36060 | CID_36060 | |
| 0.339 | 0.036 | 0.35 | Vasodilator | 0.35 0.033 CID_36060 | CID_36060 | |
| 0.297 | 0.004 | 0.388 | CYP2A6 inhibitor | 0.388 0.003 CID_36060 | CID_36060 | |
| 0.298 | 0.01 | 0.298 | Calcium channel blocker | 0.255 0.016 CID_36060 | ||
| 0.351 | 0.064 | 0.46 | Antithrombotic | 0.46 0.036 CID_36060 | CID_36060 | |
| 0.284 | 0.005 | 0.305 | Dopamine agonist | 0.305 0.005 CID_36060 | CID_36060 | |
| 0.306 | 0.039 | 0.306 | Anticonvulsant | 0.269 0.05 CID_36060 | ||
| 0.336 | 0.071 | 0.336 | Cholesterol antagonist | 0.313 0.083 CID_36060 | ||
| 0.276 | 0.012 | 0.276 | Antihistaminic | 0.186 0.023 CID_36060 | ||
| 0.267 | 0.012 | 0.267 | Histamine antagonist | 0.176 0.023 CID_36060 | ||
| 0.285 | 0.031 | 0.285 | Peptidyltransferase inhibitor | 0.274 0.036 CID_36060 | ||
| 0.335 | 0.082 | 0.337 | Transcription factor NF kappa B inhibitor | 0.337 0.081 CID_36060 | CID_36060 | |
| 0.252 | 0.004 | 0.252 | Histamine H2 receptor antagonist | 0.162 0.008 CID_36060 | ||
| 0.246 | 0.01 | 0.246 | Mediator release inhibitor | 0.198 0.015 CID_36060 | ||
| 0.254 | 0.022 | 0.273 | Alpha-N-acetylglucosaminidase inhibitor | 0.273 0.019 CID_36060 | CID_36060 | |
| 0.255 | 0.027 | 0.298 | MAP kinase kinase 3 inhibitor | 0.298 0.008 CID_36060 | CID_36060 | |
| 0.226 | 0.004 | 0.308 | Histamine N-methyltransferase inhibitor | 0.308 0.003 CID_36060 | CID_36060 | |
| 0.214 | 0.009 | 0.214 | Adenylate cyclase stimulant | 0.191 0.018 CID_36060 | ||
| 0.217 | 0.015 | 0.217 | Alpha 2 adrenoreceptor antagonist | 0.152 0.027 CID_36060 | ||
| 0.209 | 0.013 | 0.209 | Histamine H1 receptor antagonist | 0.172 0.019 CID_36060 | ||
| 0.206 | 0.012 | 0.206 | Acetylcholine nicotinic antagonist | 0.161 0.018 CID_36060 | ||
| 0.271 | 0.078 | 0.313 | Insulysin inhibitor | 0.313 0.051 CID_36060 | CID_36060 | |
| 0.204 | 0.013 | 0.204 | Alpha 2a adrenoreceptor antagonist | 0.174 0.018 CID_36060 | ||
| 0.259 | 0.072 | 0.343 | 5 Hydroxytryptamine uptake stimulant | 0.343 0.028 CID_36060 | CID_36060 | |
| 0.199 | 0.017 | 0.199 | Calcium channel (voltage-sensitive) blocker | 0.163 0.028 CID_36060 | ||
| 0.194 | 0.013 | 0.194 | Vanilloid 1 agonist | 0.186 0.016 CID_36060 | ||
| 0.249 | 0.069 | 0.307 | Tyrosine 3 hydroxylase inhibitor | 0.307 0.03 CID_36060 | CID_36060 | |
| 0.206 | 0.027 | 0.216 | Arachidonic acid antagonist | 0.216 0.02 CID_36060 | CID_36060 | |
| 0.208 | 0.031 | 0.208 | ATPase inhibitor | 0.138 0.123 CID_36060 | ||
| 0.181 | 0.005 | 0.181 | Glutamate (mGluR7) agonist | 0.142 0.015 CID_36060 | ||
| 0.215 | 0.04 | 0.215 | Antipruritic | 0.206 0.045 CID_36060 | ||
| 0.201 | 0.028 | 0.201 | GABA C receptor rho-2 antagonist | 0.16 0.061 CID_36060 | ||
| 0.23 | 0.059 | 0.249 | Anesthetic general | 0.249 0.051 CID_36060 | CID_36060 | |
| 0.249 | 0.08 | 0.249 | Gastrin inhibitor | |||
| 0.222 | 0.058 | 0.24 | Nitric-oxide synthase stimulant | 0.24 0.04 CID_36060 | CID_36060 | |
| 0.301 | 0.141 | 0.301 | Analgesic | |||
| 0.191 | 0.033 | 0.191 | 5 Hydroxytryptamine 2 antagonist | 0.125 0.056 CID_36060 | ||
| 0.167 | 0.011 | 0.167 | Adrenaline agonist | 0.116 0.027 CID_36060 | ||
| 0.185 | 0.031 | 0.185 | Alkylator | 0.135 0.056 CID_36060 | ||
| 0.171 | 0.027 | 0.171 | Calcium channel N-type blocker | 0.139 0.045 CID_36060 | ||
| 0.143 | 0.008 | 0.143 | Acetylcholine M5 receptor antagonist | 0.106 0.016 CID_36060 | ||
| 0.17 | 0.035 | 0.223 | Interleukin 4 antagonist | 0.223 0.017 CID_36060 | CID_36060 | |
| 0.134 | 0.008 | 0.134 | Beta adrenoreceptor antagonist | 0.11 0.013 CID_36060 | ||
| 0.223 | 0.098 | 0.272 | DNA damaging | 0.272 0.069 CID_36060 | CID_36060 | |
| 0.137 | 0.012 | 0.182 | Interferon agonist | 0.182 0.007 CID_36060 | CID_36060 | |
| 0.137 | 0.013 | 0.137 | Acetylcholine M2 receptor antagonist | 0.1 0.021 CID_36060 | ||
| 0.136 | 0.013 | 0.136 | Acetylcholine M4 receptor antagonist | 0.107 0.023 CID_36060 | ||
| 0.134 | 0.013 | 0.134 | Calcium channel L-type blocker | 0.114 0.018 CID_36060 | ||
| 0.149 | 0.028 | 0.149 | 5 Hydroxytryptamine 2A antagonist | 0.114 0.04 CID_36060 | ||
| 0.146 | 0.028 | 0.146 | 5 Hydroxytryptamine 2C antagonist | 0.112 0.039 CID_36060 | ||
| 0.153 | 0.035 | 0.153 | Antiadrenergic | |||
| 0.147 | 0.034 | 0.147 | Alpha 2c adrenoreceptor antagonist | 0.112 0.056 CID_36060 | ||
| 0.182 | 0.069 | 0.182 | Lipocortins synthesis antagonist | 0.18 0.071 CID_36060 | ||
| 0.147 | 0.035 | 0.147 | Adrenaline antagonist | |||
| 0.218 | 0.111 | 0.218 | 5 Hydroxytryptamine 1E antagonist | 0.172 0.164 CID_36060 | ||
| 0.141 | 0.035 | 0.261 | GABA C receptor antagonist | 0.261 0.005 CID_36060 | CID_36060 | |
| 0.135 | 0.029 | 0.174 | GABA C receptor rho-1 antagonist | 0.174 0.013 CID_36060 | CID_36060 | |
| 0.11 | 0.005 | 0.11 | 5 Hydroxytryptamine 1B agonist | 0.088 0.01 CID_36060 | ||
| 0.13 | 0.026 | 0.145 | MAP kinase kinase 1 inhibitor | 0.145 0.018 CID_36060 | CID_36060 | |
| 0.152 | 0.049 | 0.152 | 5 Hydroxytryptamine antagonist | 0.106 0.074 CID_36060 | ||
| 0.108 | 0.01 | 0.135 | Interferon inducer | 0.135 0.005 CID_36060 | CID_36060 | |
| 0.108 | 0.01 | 0.108 | Phospholipase D inhibitor | 0.069 0.056 CID_36060 | ||
| 0.113 | 0.015 | 0.113 | Acetylcholine M3 receptor antagonist | 0.085 0.024 CID_36060 | ||
| 0.099 | 0.004 | 0.146 | Cytokine production stimulant | 0.146 0.003 CID_36060 | CID_36060 | |
| 0.113 | 0.02 | 0.166 | Phenylalanine 4-hydroxylase inhibitor | 0.166 0.01 CID_36060 | CID_36060 | |
| 0.129 | 0.037 | 0.199 | Adenylate kinase inhibitor | 0.199 0.015 CID_36060 | CID_36060 | |
| 0.117 | 0.028 | 0.141 | Ornithine decarboxylase inhibitor | 0.141 0.014 CID_36060 | CID_36060 | |
| 0.092 | 0.005 | 0.092 | Histamine H2 receptor agonist | 0.09 0.005 CID_36060 | ||
| 0.099 | 0.015 | 0.099 | Beta 3 adrenoreceptor antagonist | 0.061 0.053 CID_36060 | ||
| 0.104 | 0.02 | 0.104 | Estrogen-related receptor beta agonist | 0.093 0.034 CID_36060 | ||
| 0.203 | 0.119 | 0.216 | DNA synthesis inhibitor | 0.216 0.1 CID_36060 | CID_36060 | |
| 0.117 | 0.037 | 0.136 | Calcium antagonist | 0.136 0.027 CID_36060 | CID_36060 | |
| 0.089 | 0.009 | 0.089 | Beta 2 adrenoreceptor antagonist | 0.075 0.014 CID_36060 | ||
| 0.143 | 0.064 | 0.154 | Ca2+-transporting ATPase inhibitor | 0.154 0.034 CID_36060 | CID_36060 | |
| 0.088 | 0.011 | 0.088 | Histamine agonist | 0.072 0.018 CID_36060 | ||
| 0.136 | 0.06 | 0.141 | Antibacterial (Helicobacter pylori) | 0.141 0.055 CID_36060 | CID_36060 | |
| 0.181 | 0.106 | 0.181 | Potassium channel blocker | |||
| 0.08 | 0.005 | 0.113 | GABA uptake inhibitor | 0.113 0.003 CID_36060 | CID_36060 | |
| 0.271 | 0.2 | 0.384 | 5 Hydroxytryptamine release inhibitor | 0.384 0.089 CID_36060 | CID_36060 | |
| 0.125 | 0.056 | 0.125 | 5 Hydroxytryptamine 2B antagonist | 0.112 0.069 CID_36060 | ||
| 0.118 | 0.051 | 0.118 | Acetylcholine release stimulant | 0.099 0.09 CID_36060 | ||
| 0.091 | 0.026 | 0.091 | Alpha 1d adrenoreceptor antagonist | 0.058 0.042 CID_36060 | ||
| 0.28 | 0.216 | 0.294 | Caspase 9 stimulant | 0.294 0.201 CID_36060 | CID_36060 | |
| 0.074 | 0.01 | 0.088 | Histamine H4 receptor antagonist | 0.088 0.007 CID_36060 | CID_36060 | |
| 0.069 | 0.006 | 0.069 | 5 Hydroxytryptamine 1D agonist | 0.045 0.012 CID_36060 | ||
| 0.08 | 0.018 | 0.08 | Beta 1 adrenoreceptor antagonist | |||
| 0.082 | 0.021 | 0.11 | Acyl-CoA dehydrogenase inhibitor | 0.11 0.014 CID_36060 | CID_36060 | |
| 0.08 | 0.02 | 0.08 | NMDA 2A receptor antagonist | 0.073 0.023 CID_36060 | ||
| 0.111 | 0.051 | 0.111 | Alpha adrenoreceptor antagonist | |||
| 0.11 | 0.051 | 0.141 | UDP-glucose 4-epimerase inhibitor | 0.141 0.032 CID_36060 | CID_36060 | |
| 0.073 | 0.014 | 0.073 | Beta 2 adrenoreceptor agonist | 0.073 0.015 CID_36060 | ||
| 0.107 | 0.049 | 0.107 | Nitric-oxide synthase inhibitor | |||
| 0.07 | 0.012 | 0.07 | Adenylate cyclase 1 inhibitor | 0.065 0.015 CID_36060 | ||
| 0.142 | 0.084 | 0.157 | Diuretic | 0.157 0.072 CID_36060 | CID_36060 | |
| 0.078 | 0.023 | 0.083 | Calcium channel T-type blocker | 0.083 0.021 CID_36060 | CID_36060 | |
| 0.094 | 0.039 | 0.094 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.07 | 0.017 | 0.07 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.092 | 0.039 | 0.118 | Na+ K+ transporting ATPase inhibitor | 0.118 0.017 CID_36060 | CID_36060 | |
| 0.107 | 0.056 | 0.107 | Gastric antisecretory | |||
| 0.082 | 0.032 | 0.082 | Dopamine D1 antagonist | 0.058 0.052 CID_36060 | ||
| 0.066 | 0.016 | 0.066 | Squalene epoxidase inhibitor | 0.056 0.024 CID_36060 | ||
| 0.076 | 0.026 | 0.076 | 5 Hydroxytryptamine 1 agonist | |||
| 0.095 | 0.047 | 0.095 | Bromodomain-containing protein 2 inhibitor | 0.086 0.063 CID_36060 | ||
| 0.068 | 0.02 | 0.082 | Epithelial sodium channel blocker | 0.082 0.012 CID_36060 | CID_36060 | |
| 0.075 | 0.027 | 0.075 | Alpha 2 adrenoreceptor agonist | |||
| 0.114 | 0.066 | 0.133 | Photosensitizer | 0.133 0.043 CID_36060 | CID_36060 | |
| 0.088 | 0.041 | 0.094 | T cell inhibitor | 0.094 0.031 CID_36060 | CID_36060 | |
| 0.066 | 0.02 | 0.076 | Alpha-mannosidase inhibitor | 0.076 0.013 CID_36060 | CID_36060 | |
| 0.068 | 0.021 | 0.068 | Myc inhibitor | |||
| 0.067 | 0.02 | 0.067 | Histamine H3 receptor antagonist | 0.042 0.032 CID_36060 | ||
| 0.153 | 0.107 | 0.205 | Succinate dehydrogenase inhibitor | 0.205 0.045 CID_36060 | CID_36060 | |
| 0.073 | 0.027 | 0.073 | 5 Hydroxytryptamine 6 antagonist | 0.067 0.031 CID_36060 | ||
| 0.055 | 0.011 | 0.055 | Beta adrenoreceptor agonist | 0.05 0.019 CID_36060 | ||
| 0.105 | 0.062 | 0.289 | GABA C receptor agonist | 0.289 0.01 CID_36060 | CID_36060 | |
| 0.118 | 0.076 | 0.118 | DNA repair enzyme inhibitor | |||
| 0.105 | 0.062 | 0.181 | Aminopeptidase B inhibitor | 0.181 0.026 CID_36060 | CID_36060 | |
| 0.094 | 0.054 | 0.149 | Triose-phosphate isomerase inhibitor | 0.149 0.02 CID_36060 | CID_36060 | |
| 0.093 | 0.053 | 0.131 | NADH dehydrogenase inhibitor | 0.131 0.023 CID_36060 | CID_36060 | |
| 0.08 | 0.04 | 0.08 | 5 Hydroxytryptamine 1A antagonist | 0.064 0.05 CID_36060 | ||
| 0.093 | 0.055 | 0.1 | Glutamate release inhibitor | 0.1 0.043 CID_36060 | CID_36060 | |
| 0.112 | 0.074 | 0.118 | Adenylate cyclase inhibitor | 0.118 0.069 CID_36060 | CID_36060 | |
| 0.118 | 0.08 | 0.15 | Cyclooxygenase 3 inhibitor | 0.15 0.048 CID_36060 | CID_36060 | |
| 0.052 | 0.015 | 0.052 | Histamine H1 receptor agonist | 0.05 0.018 CID_36060 | ||
| 0.051 | 0.014 | 0.057 | Diamine oxidase inhibitor | 0.057 0.011 CID_36060 | CID_36060 | |
| 0.081 | 0.044 | 0.122 | Glutamate dehydrogenase inhibitor | 0.122 0.022 CID_36060 | CID_36060 | |
| 0.088 | 0.051 | 0.088 | mTOR complex 2 inhibitor | |||
| 0.07 | 0.033 | 0.131 | NMDA 2C receptor antagonist | 0.131 0.009 CID_36060 | CID_36060 | |
| 0.158 | 0.122 | 0.158 | HERG channel blocker | |||
| 0.065 | 0.029 | 0.065 | Ca(v)3.2 blocker | 0.061 0.037 CID_36060 | ||
| 0.04 | 0.005 | 0.04 | Estrogen-related receptor gamma antagonist | 0.028 0.022 CID_36060 | ||
| 0.12 | 0.085 | 0.12 | Toll-Like receptor 9 antagonist | |||
| 0.045 | 0.011 | 0.045 | Sigma 2 receptor antagonist | 0.025 0.02 CID_36060 | ||
| 0.067 | 0.035 | 0.067 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.156 | 0.125 | 0.158 | Insulin sensitizer | 0.158 0.122 CID_36060 | CID_36060 | |
| 0.149 | 0.118 | 0.573 | Interleukin antagonist | 0.573 0.014 CID_36060 | CID_36060 | |
| 0.053 | 0.022 | 0.074 | Mannosidase inhibitor | 0.074 0.01 CID_36060 | CID_36060 | |
| 0.13 | 0.1 | 0.231 | Phospholipase A2 inhibitor | 0.231 0.029 CID_36060 | CID_36060 | |
| 0.174 | 0.145 | 0.238 | Interleukin agonist | 0.238 0.088 CID_36060 | CID_36060 | |
| 0.058 | 0.03 | 0.061 | Thromboxane synthase inhibitor | 0.061 0.026 CID_36060 | CID_36060 | |
| 0.069 | 0.042 | 0.069 | Fibroblast growth factor 2 antagonist | |||
| 0.032 | 0.005 | 0.032 | Alpha 2a adrenoreceptor agonist | 0.025 0.006 CID_36060 | ||
| 0.094 | 0.067 | 0.115 | Electrolyte absorption antagonist | 0.115 0.041 CID_36060 | CID_36060 | |
| 0.061 | 0.036 | 0.061 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.122 | 0.098 | 0.335 | Peroxidase inhibitor | 0.335 0.031 CID_36060 | CID_36060 | |
| 0.21 | 0.186 | 0.298 | Immunosuppressant | 0.298 0.116 CID_36060 | CID_36060 | |
| 0.056 | 0.034 | 0.056 | Immunoglobulin Fc receptor antagonist | 0.053 0.048 CID_36060 | ||
| 0.128 | 0.105 | 0.128 | Sigma receptor agonist | |||
| 0.111 | 0.088 | 0.155 | Cathepsin H inhibitor | 0.155 0.043 CID_36060 | CID_36060 | |
| 0.033 | 0.01 | 0.033 | Myristoyl transferase inhibitor | |||
| 0.081 | 0.06 | 0.081 | Inducible nitric-oxide synthase inhibitor | |||
| 0.03 | 0.009 | 0.03 | Acid ceramidase inhibitor | |||
| 0.155 | 0.134 | 0.155 | MAP kinase kinase 5 inhibitor | |||
| 0.072 | 0.051 | 0.107 | Aminopeptidase I inhibitor | 0.107 0.025 CID_36060 | CID_36060 | |
| 0.104 | 0.084 | 0.138 | Beta amyloid protein antagonist | 0.138 0.05 CID_36060 | CID_36060 | |
| 0.027 | 0.007 | 0.027 | Calcium-sensing receptor antagonist | 0.015 0.01 CID_36060 | ||
| 0.06 | 0.041 | 0.06 | Carbonic anhydrase stimulant | 0.059 0.041 CID_36060 | ||
| 0.106 | 0.088 | 0.122 | MAP kinase kinase inhibitor | 0.122 0.072 CID_36060 | CID_36060 | |
| 0.047 | 0.029 | 0.047 | Dopamine D2 agonist | 0.041 0.034 CID_36060 | ||
| 0.049 | 0.031 | 0.066 | Glycine transporter 2 inhibitor | 0.066 0.022 CID_36060 | CID_36060 | |
| 0.072 | 0.054 | 0.099 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.099 0.014 CID_36060 | CID_36060 | |
| 0.078 | 0.061 | 0.078 | Opioid kappa receptor antagonist | |||
| 0.037 | 0.02 | 0.037 | Prostacyclin antagonist | 0.037 0.02 CID_36060 | ||
| 0.152 | 0.135 | 0.152 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.104 | 0.088 | 0.104 | Interleukin 8 antagonist | |||
| 0.06 | 0.045 | 0.06 | Dopamine D3 antagonist | |||
| 0.17 | 0.155 | 0.358 | Superoxide dismutase inhibitor | 0.358 0.035 CID_36060 | CID_36060 | |
| 0.072 | 0.058 | 0.072 | Alpha 1 adrenoreceptor antagonist | |||
| 0.022 | 0.008 | 0.022 | Alpha 2c adrenoreceptor agonist | 0.017 0.015 CID_36060 | ||
| 0.037 | 0.023 | 0.037 | Ceramide glucosyltransferase inhibitor | 0.036 0.025 CID_36060 | ||
| 0.05 | 0.036 | 0.05 | Alpha 1b adrenoreceptor agonist | |||
| 0.046 | 0.033 | 0.046 | Potassium channel Kv1.3 blocker | |||
| 0.064 | 0.051 | 0.064 | Alpha adrenoreceptor agonist | |||
| 0.021 | 0.009 | 0.021 | Estrogen-related receptor gamma agonist | |||
| 0.14 | 0.128 | 0.152 | Neurotensin receptor agonist | 0.152 0.097 CID_36060 | CID_36060 | |
| 0.081 | 0.069 | 0.138 | Vanilloid agonist | 0.138 0.013 CID_36060 | CID_36060 | |
| 0.026 | 0.015 | 0.026 | Lysophosphatidic acid receptor 1 agonist | 0.026 0.016 CID_36060 | ||
| 0.071 | 0.061 | 0.071 | Vanilloid 4 agonist | |||
| 0.053 | 0.043 | 0.082 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.082 0.019 CID_36060 | CID_36060 | |
| 0.036 | 0.026 | 0.036 | Renin inhibitor | |||
| 0.041 | 0.031 | 0.042 | Oxytocin agonist | 0.042 0.03 CID_36060 | CID_36060 | |
| 0.045 | 0.036 | 0.045 | Baculoviral IAP repeat-containing protein inhibitor | |||
| 0.038 | 0.028 | 0.038 | Alpha 1d adrenoreceptor agonist | 0.036 0.031 CID_36060 | ||
| 0.079 | 0.069 | 0.096 | Myeloperoxidase inhibitor | 0.096 0.04 CID_36060 | CID_36060 | |
| 0.081 | 0.072 | 0.099 | Granulocyte macrophage colony stimulating factor agonist | 0.099 0.036 CID_36060 | CID_36060 | |
| 0.052 | 0.043 | 0.053 | Glucosylceramidase inhibitor | 0.053 0.041 CID_36060 | CID_36060 | |
| 0.089 | 0.08 | 0.102 | Anabolic | 0.102 0.06 CID_36060 | CID_36060 | |
| 0.024 | 0.016 | 0.024 | Dopamine autoreceptor agonist | |||
| 0.074 | 0.066 | 0.089 | MAP kinase kinase 7 inhibitor | 0.089 0.027 CID_36060 | CID_36060 | |
| 0.105 | 0.097 | 0.136 | Toll-Like receptor 2 antagonist | 0.136 0.063 CID_36060 | CID_36060 | |
| 0.027 | 0.02 | 0.027 | Hedgehog signaling activator | |||
| 0.06 | 0.054 | 0.06 | Neuronal nicotinic receptor antagonist | |||
| 0.044 | 0.04 | 0.055 | Glucose-6-phosphate isomerase inhibitor | 0.055 0.023 CID_36060 | CID_36060 | |
| 0.109 | 0.104 | 0.109 | Toll-Like receptor antagonist | |||
| 0.037 | 0.033 | 0.043 | Toll-Like receptor 2 agonist | 0.043 0.027 CID_36060 | CID_36060 | |
| 0.041 | 0.037 | 0.041 | 5 Hydroxytryptamine 1A agonist | |||
| 0.06 | 0.056 | 0.111 | Phosphofructokinase-1 inhibitor | 0.111 0.028 CID_36060 | CID_36060 | |
| 0.02 | 0.016 | 0.026 | Geranylgeranyltransferase I inhibitor | 0.026 0.01 CID_36060 | CID_36060 | |
| 0.027 | 0.024 | 0.033 | Purinergic P2Y15 antagonist | 0.033 0.013 CID_36060 | CID_36060 | |
| 0.059 | 0.056 | 0.059 | 5 Hydroxytryptamine agonist | |||
| 0.069 | 0.067 | 0.071 | Potassium channel (Tandem pore domain) blocker | 0.071 0.059 CID_36060 | CID_36060 | |
| 0.053 | 0.051 | 0.102 | Carbamoyl phosphate synthetase inhibitor | 0.102 0.02 CID_36060 | CID_36060 | |
| 0.024 | 0.023 | 0.024 | Integrin alpha2beta1 antagonist | |||
| 0.016 | 0.015 | 0.035 | Sodium/hydrogen exchanger inhibitor | 0.035 0.004 CID_36060 | CID_36060 | |
| 0.031 | 0.03 | 0.031 | Melatonin receptor 1A agonist | |||
| 0.045 | 0.044 | 0.059 | Dopamine beta hydroxylase inhibitor | 0.059 0.016 CID_36060 | CID_36060 | |
| 0.053 | 0.054 | 0.09 | 5 Hydroxytryptamine 2A agonist | 0.09 0.019 CID_36060 | CID_36060 | |
| 0.057 | 0.059 | 0.078 | Leukotriene synthesis inhibitor | 0.078 0.039 CID_36060 | CID_36060 | |
| 0.079 | 0.081 | 0.088 | MAO A inhibitor | 0.088 0.073 CID_36060 | CID_36060 | |
| 0.117 | 0.121 | 0.148 | Hemostatic | 0.148 0.07 CID_36060 | CID_36060 | |
| 0.039 | 0.044 | 0.047 | Farnesyltransferase inhibitor | 0.047 0.03 CID_36060 | CID_36060 | |
| 0.149 | 0.155 | 0.238 | Immunostimulant | 0.238 0.101 CID_36060 | CID_36060 | |
| 0.08 | 0.087 | 0.134 | Creatine kinase inhibitor | 0.134 0.032 CID_36060 | CID_36060 | |
| 0.096 | 0.104 | 0.129 | Aldehyde dehydrogenase inhibitor | 0.129 0.063 CID_36060 | CID_36060 | |
| 0.028 | 0.036 | 0.034 | Glutamate (mGluR3) agonist | 0.034 0.018 CID_36060 | CID_36060 | |
| 0.068 | 0.076 | 0.121 | Protein kinase A inhibitor | 0.121 0.033 CID_36060 | CID_36060 | |
| 0.016 | 0.025 | 0.018 | Antibiotic Anthracycline-like | 0.018 0.016 CID_36060 | CID_36060 | |
| 0.055 | 0.064 | 0.064 | Protease 3C (Human rhinovirus) inhibitor | 0.064 0.046 CID_36060 | CID_36060 | |
| 0.016 | 0.025 | 0.017 | Methylmalonyl-CoA mutase inhibitor | 0.017 0.016 CID_36060 | CID_36060 | |
| 0.041 | 0.05 | 0.055 | 5 Hydroxytryptamine 2 agonist | 0.055 0.032 CID_36060 | CID_36060 | |
| 0.043 | 0.053 | 0.075 | Aconitate hydratase inhibitor | 0.075 0.016 CID_36060 | CID_36060 | |
| 0.076 | 0.087 | 0.083 | Prolactin inhibitor | 0.083 0.077 CID_36060 | CID_36060 | |
| 0.018 | 0.03 | 0.031 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.031 0.017 CID_36060 | CID_36060 | |
| 0.028 | 0.041 | 0.041 | Retinoid X alpha receptor antagonist | 0.041 0.014 CID_36060 | CID_36060 | |
| 0.133 | 0.146 | 0.188 | Phospholipase C inhibitor | 0.188 0.053 CID_36060 | CID_36060 | |
| 0.012 | 0.025 | 0.02 | Cyclin T1 inhibitor | 0.02 0.011 CID_36060 | CID_36060 | |
| 0.06 | 0.073 | 0.081 | Exportin-1 inhibitor | 0.081 0.023 CID_36060 | CID_36060 | |
| 0.052 | 0.066 | 0.066 | Acetylcholine M5 receptor agonist | 0.066 0.048 CID_36060 | CID_36060 | |
| 0.075 | 0.089 | 0.174 | Check point kinase 2 inhibitor | 0.174 0.024 CID_36060 | CID_36060 | |
| 0.041 | 0.055 | 0.047 | Bombesin 2 receptor antagonist | 0.047 0.038 CID_36060 | CID_36060 | |
| 0.078 | 0.092 | 0.103 | Urease inhibitor | 0.103 0.064 CID_36060 | CID_36060 | |
| 0.132 | 0.147 | 0.152 | Non-steroidal antiinflammatory agent | 0.152 0.113 CID_36060 | CID_36060 | |
| 0.03 | 0.045 | 0.046 | Retinoid X receptor antagonist | 0.046 0.016 CID_36060 | CID_36060 | |
| 0.044 | 0.059 | 0.051 | Leukotriene B4 antagonist | 0.051 0.042 CID_36060 | CID_36060 | |
| 0.008 | 0.023 | 0.012 | Lysophosphatidic acid receptor 3 agonist | 0.012 0.011 CID_36060 | CID_36060 | |
| 0.037 | 0.055 | 0.053 | Carbonic anhydrase XIV inhibitor | 0.053 0.03 CID_36060 | CID_36060 | |
| 0.079 | 0.1 | 0.158 | Ferrochelatase inhibitor | 0.158 0.034 CID_36060 | CID_36060 | |
| 0.04 | 0.062 | 0.311 | Alcohol oxidase inhibitor | 0.311 0.004 CID_36060 | CID_36060 | |
| 0.167 | 0.189 | 0.187 | Neuropeptide Y2 antagonist | 0.187 0.145 CID_36060 | CID_36060 | |
| 0.016 | 0.039 | 0.035 | Uridine phosphorylase inhibitor | 0.035 0.015 CID_36060 | CID_36060 | |
| 0.144 | 0.166 | 0.185 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.185 0.087 CID_36060 | CID_36060 | |
| 0.076 | 0.099 | 0.101 | Lanosterol 14 alpha demethylase inhibitor | 0.101 0.054 CID_36060 | CID_36060 | |
| 0.035 | 0.059 | 0.084 | Ornithine carbamoyltransferase inhibitor | 0.084 0.02 CID_36060 | CID_36060 | |
| 0.009 | 0.035 | 0.017 | Carbonic anhydrase X inhibitor | 0.017 0.011 CID_36060 | CID_36060 | |
| 0.009 | 0.035 | 0.017 | Carbonic anhydrase VIII inhibitor | 0.017 0.011 CID_36060 | CID_36060 | |
| 0.084 | 0.11 | 0.098 | Protein kinase C gamma inhibitor | 0.098 0.08 CID_36060 | CID_36060 | |
| 0.042 | 0.068 | 0.094 | Biliverdin reductase inhibitor | 0.094 0.02 CID_36060 | CID_36060 | |
| 0.046 | 0.076 | 0.062 | Sphingosine 1-phosphate receptor 4 agonist | 0.062 0.052 CID_36060 | CID_36060 | |
| 0.063 | 0.096 | 0.092 | GABA B receptor agonist | 0.092 0.023 CID_36060 | CID_36060 | |
| 0.015 | 0.051 | 0.021 | Toll-Like receptor 8 agonist | 0.021 0.011 CID_36060 | CID_36060 | |
| 0.026 | 0.062 | 0.057 | Dopamine D5 agonist | 0.057 0.013 CID_36060 | CID_36060 | |
| 0.051 | 0.088 | 0.127 | Glutamate decarboxylase inhibitor | 0.127 0.019 CID_36060 | CID_36060 | |
| 0.063 | 0.103 | 0.083 | Glutathione S-transferase inhibitor | 0.083 0.056 CID_36060 | CID_36060 | |
| 0.099 | 0.139 | 0.126 | Cell wall synthesis inhibitor | 0.126 0.091 CID_36060 | CID_36060 | |
| 0.076 | 0.117 | 0.133 | Carbonic anhydrase XV inhibitor | 0.133 0.038 CID_36060 | CID_36060 | |
| 0.019 | 0.062 | 0.038 | Phosphoglycerate kinase inhibitor | 0.038 0.021 CID_36060 | CID_36060 | |
| 0.031 | 0.075 | 0.039 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.039 0.035 CID_36060 | CID_36060 | |
| 0.076 | 0.123 | 0.108 | Mucolytic | 0.108 0.067 CID_36060 | CID_36060 | |
| 0.013 | 0.06 | 0.024 | Lysine carboxypeptidase inhibitor | 0.024 0.022 CID_36060 | CID_36060 | |
| 0.014 | 0.06 | 0.022 | Isoleucine-tRNA ligase inhibitor | 0.022 0.017 CID_36060 | CID_36060 | |
| 0.053 | 0.1 | 0.082 | Glutamate (mGluR6) antagonist | 0.082 0.022 CID_36060 | CID_36060 | |
| 0.033 | 0.083 | 0.067 | Argininosuccinate synthase inhibitor | 0.067 0.032 CID_36060 | CID_36060 | |
| 0.01 | 0.062 | 0.019 | Imidazoline I1 receptor antagonist | 0.019 0.017 CID_36060 | CID_36060 | |
| 0.022 | 0.074 | 0.032 | Carboxypeptidase B inhibitor | 0.032 0.025 CID_36060 | CID_36060 | |
| 0.037 | 0.09 | 0.054 | Sphingosine kinase 2 inhibitor | 0.054 0.04 CID_36060 | CID_36060 | |
| 0.064 | 0.121 | 0.106 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.106 0.048 CID_36060 | CID_36060 | |
| 0.016 | 0.073 | 0.033 | Fumarate hydratase inhibitor | 0.033 0.025 CID_36060 | CID_36060 | |
| 0.022 | 0.079 | 0.05 | Glutamate (mGluR3) antagonist | 0.05 0.012 CID_36060 | CID_36060 | |
| 0.015 | 0.077 | 0.024 | Thyroid hormone agonist | 0.024 0.023 CID_36060 | CID_36060 | |
| 0.044 | 0.108 | 0.067 | Cathepsin G inhibitor | 0.067 0.057 CID_36060 | CID_36060 | |
| 0.051 | 0.116 | 0.108 | Glycine receptor agonist | 0.108 0.017 CID_36060 | CID_36060 | |
| 0.068 | 0.133 | 0.102 | MAO inhibitor | 0.102 0.088 CID_36060 | CID_36060 | |
| 0.066 | 0.132 | 0.1 | Carbonic anhydrase III inhibitor | 0.1 0.062 CID_36060 | CID_36060 | |
| 0.015 | 0.085 | 0.116 | Kinesin antagonist | 0.116 0.006 CID_36060 | CID_36060 | |
| 0.015 | 0.085 | 0.116 | Kinesin-like protein 1 inhibitor | 0.116 0.006 CID_36060 | CID_36060 | |
| 0.038 | 0.114 | 0.11 | Histidine decarboxylase inhibitor | 0.11 0.028 CID_36060 | CID_36060 | |
| 0.027 | 0.107 | 0.038 | Kainate receptor agonist | 0.038 0.037 CID_36060 | CID_36060 | |
| 0.119 | 0.2 | 0.134 | Heat shock protein 70 antagonist | 0.134 0.101 CID_36060 | CID_36060 | |
| 0.026 | 0.111 | 0.051 | Maillard reaction inhibitor | 0.051 0.042 CID_36060 | CID_36060 | |
| 0.023 | 0.109 | 0.037 | Glutamate (mGluR8) agonist | 0.037 0.029 CID_36060 | CID_36060 | |
| 0.046 | 0.132 | 0.089 | GABA aminotransferase inhibitor | 0.089 0.036 CID_36060 | CID_36060 | |
| 0.042 | 0.128 | 0.085 | MAO B inhibitor | 0.085 0.071 CID_36060 | CID_36060 | |
| 0.04 | 0.13 | 0.075 | Protein kinase B beta inhibitor | 0.075 0.049 CID_36060 | CID_36060 | |
| 0.015 | 0.106 | 0.039 | Vascular adhesion protein 1 inhibitor | 0.039 0.026 CID_36060 | CID_36060 | |
| 0.048 | 0.139 | 0.074 | Carbonic anhydrase VI inhibitor | 0.074 0.065 CID_36060 | CID_36060 | |
| 0.027 | 0.12 | 0.041 | Glutamate (mGluR4) antagonist | 0.041 0.035 CID_36060 | CID_36060 | |
| 0.137 | 0.235 | 0.182 | RNA-directed DNA polymerase inhibitor | 0.182 0.13 CID_36060 | CID_36060 | |
| 0.058 | 0.157 | 0.094 | Cystathionine beta-synthase inhibitor | 0.094 0.084 CID_36060 | CID_36060 | |
| 0.039 | 0.141 | 0.08 | Protein kinase B alpha inhibitor | 0.08 0.04 CID_36060 | CID_36060 | |
| 0.047 | 0.151 | 0.091 | Keratolytic | 0.091 0.037 CID_36060 | CID_36060 | |
| 0.033 | 0.141 | 0.117 | Porphobilinogen synthase inhibitor | 0.117 0.029 CID_36060 | CID_36060 | |
| 0.037 | 0.146 | 0.056 | Corticotropin releasing factor 2 receptor antagonist | 0.056 0.055 CID_36060 | CID_36060 | |
| 0.053 | 0.179 | 0.117 | 5 Hydroxytryptamine 3A agonist | 0.117 0.059 CID_36060 | CID_36060 | |
| 0.157 | 0.287 | 0.264 | Antibacterial | 0.264 0.164 CID_36060 | CID_36060 | |
| 0.056 | 0.187 | 0.119 | Amylase inhibitor | 0.119 0.082 CID_36060 | CID_36060 | |
| 0.062 | 0.205 | 0.101 | DOPA decarboxylase inhibitor | 0.101 0.074 CID_36060 | CID_36060 | |
| 0.044 | 0.193 | 0.093 | HIV-1 integrase (Overall Integration) inhibitor | 0.093 0.061 CID_36060 | CID_36060 | |
| 0.018 | 0.17 | 0.047 | Neuraminidase (Influenza A) inhibitor | 0.047 0.028 CID_36060 | CID_36060 | |
| 0.028 | 0.18 | 0.051 | Parathyroid hormone antagonist | 0.051 0.02 CID_36060 | CID_36060 | |
| 0.119 | 0.275 | 0.191 | Transcription factor STAT3 inhibitor | 0.191 0.147 CID_36060 | CID_36060 | |
| 0.043 | 0.202 | 0.084 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.084 0.057 CID_36060 | CID_36060 | |
| 0.033 | 0.206 | 0.105 | Protein kinase B gamma inhibitor | 0.105 0.03 CID_36060 | CID_36060 | |
| 0.085 | 0.277 | 0.172 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.172 0.102 CID_36060 | CID_36060 | |
| 0.031 | 0.241 | 0.081 | Somatostatin 1 agonist | 0.081 0.05 CID_36060 | CID_36060 | |
| 0.043 | 0.264 | 0.264 | Thrombolytic | 0.264 0.03 CID_36060 | CID_36060 | |
| 0.007 | 0.25 | 0.027 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.024 CID_36060 | CID_36060 | |
| 0.083 | 0.34 | 0.171 | Hypoglycemic | 0.171 0.145 CID_36060 | CID_36060 | |
| 0.05 | 0.314 | 0.105 | CDC-like kinase 3 inhibitor | 0.105 0.069 CID_36060 | CID_36060 | |
| 0.054 | 0.352 | 0.218 | Platelet antagonist | 0.218 0.089 CID_36060 | CID_36060 | |
| 0.061 | 0.38 | 0.176 | Growth hormone agonist | 0.176 0.07 CID_36060 | CID_36060 | |
| 0.045 | 0.397 | 0.086 | Interleukin 12 antagonist | 0.086 0.081 CID_36060 | CID_36060 | |
| 0.101 | 0.475 | 0.262 | Interleukin 2 agonist | 0.262 0.106 CID_36060 | CID_36060 | |
| 0.006 | 0.401 | 0.07 | Urokinase inhibitor | 0.07 0.024 CID_36060 | CID_36060 | |
| 0.023 | 0.453 | 0.133 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.133 0.103 CID_36060 | CID_36060 | |
| 0.013 | 0.637 | 0.153 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.153 0.117 CID_36060 | CID_36060 | |
| 0.012 | 0.737 | 0.113 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.113 0.108 CID_36060 | CID_36060 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |